Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease.
Cappuccio
Francesco P
FP
Clinical Sciences Research Institute, University of Warwick Medical School, Coventry CV2 2DX. f.p.cappuccio@warwick.ac.uk
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003376:Counseling; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008019:Life Style; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents